Insulin glargine/lixisenatide fixed ratio formulation
First Claim
Patent Images
1. A method of improving glycemic control in a patient with type 2 diabetes mellitus in need thereof, the method comprising administering to the patient a pharmaceutical composition comprising:
- (a) lixisenatide or a pharmaceutically acceptable salt thereof at a concentration of 33 μ
g/mL, and(b) insulin glargine or a pharmaceutically acceptable salt thereof at a concentration of 100 U/mLwherein the patient'"'"'s type 2 diabetes mellitus is inadequately controlled by treatment with lixisenatide.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention refers to a pharmaceutical composition comprising (a) lixisenatide or/and a pharmaceutically acceptable salt thereof, and (b) insulin glargine or/and a pharmaceutically acceptable salt thereof, wherein the compound (b) and compound (a) are present in a fixed ratio.
-
Citations
7 Claims
-
1. A method of improving glycemic control in a patient with type 2 diabetes mellitus in need thereof, the method comprising administering to the patient a pharmaceutical composition comprising:
-
(a) lixisenatide or a pharmaceutically acceptable salt thereof at a concentration of 33 μ
g/mL, and(b) insulin glargine or a pharmaceutically acceptable salt thereof at a concentration of 100 U/mL wherein the patient'"'"'s type 2 diabetes mellitus is inadequately controlled by treatment with lixisenatide. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification